For research use only. Not for therapeutic Use.
Cefpirome sulfate（Cat No.:I005730）is a fourth-generation cephalosporin antibiotic effective against a wide range of gram-positive and gram-negative bacteria, including some strains resistant to earlier cephalosporins. It functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Cefpirome is often used in hospital settings to treat severe infections, such as sepsis, pneumonia, and urinary tract infections, where multidrug resistance is a concern. Its broad-spectrum action and stability against beta-lactamases make Cefpirome sulfate a valuable option in managing critical infections in immunocompromised and high-risk patients.
| Catalog Number | I005730 |
| CAS Number | 98753-19-6 |
| Molecular Formula | C22H22N6O5S2H2SO4 (Cefpirome Sulfate) |
| Purity | ≥95% |
| Solubility | DMSO:44mg/mL |
| Storage | Store at 4℃ |
| IUPAC Name | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;sulfuric acid |
| InChI | InChI=1S/C22H22N6O5S2.H2O4S/c1-33-26-15(13-10-35-22(23)24-13)18(29)25-16-19(30)28-17(21(31)32)12(9-34-20(16)28)8-27-7-3-5-11-4-2-6-14(11)27;1-5(2,3)4/h3,5,7,10,16,20H,2,4,6,8-9H2,1H3,(H3-,23,24,25,29,31,32);(H2,1,2,3,4)/b26-15-;/t16-,20-;/m1./s1 |
| InChIKey | RKTNPKZEPLCLSF-QHBKFCFHSA-N |
| SMILES | CO/N=C(/C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-].OS(=O)(=O)O |
| Reference | [1].The erratic antibiotic susceptibility patterns of bacterial pathogens causing urinary tract infections.<br /> |
